• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒 58 型 E7 癌蛋白调节细胞周期调控蛋白并消除细胞周期检查点。

The human papillomavirus type 58 E7 oncoprotein modulates cell cycle regulatory proteins and abrogates cell cycle checkpoints.

机构信息

Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

出版信息

Virology. 2010 Feb 5;397(1):139-44. doi: 10.1016/j.virol.2009.10.051. Epub 2009 Nov 27.

DOI:10.1016/j.virol.2009.10.051
PMID:19945133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2818596/
Abstract

HPV type 58 (HPV-58) is the third most common HPV type in cervical cancer from Eastern Asia, yet little is known about how it promotes carcinogenesis. In this study, we demonstrate that HPV-58 E7 significantly promoted the proliferation and extended the lifespan of primary human keratinocytes (PHKs). HPV-58 E7 abrogated the G1 and the postmitotic checkpoints, although less efficiently than HPV-16 E7. Consistent with these observations, HPV-58 E7 down-regulated the cellular tumor suppressor pRb to a lesser extent than HPV-16 E7. Similar to HPV-16 E7 expressing PHKs, Cdk2 remained active in HPV-58 E7 expressing PHKs despite the presence of elevated levels of p53 and p21. Interestingly, HPV-58 E7 down-regulated p130 more efficiently than HPV-16 E7. Our study demonstrates a correlation between the ability of down-regulating pRb/p130 and abrogating cell cycle checkpoints by HPV-58 E7, which also correlates with the biological risks of cervical cancer progression associated with HPV-58 infection.

摘要

HPV 型 58(HPV-58)是东亚宫颈癌中第三常见的 HPV 型,但人们对其如何促进致癌作用知之甚少。在这项研究中,我们证明 HPV-58 E7 可显著促进原代人角质形成细胞(PHK)的增殖并延长其寿命。HPV-58 E7 废除了 G1 和有丝分裂后检查点,尽管效率不如 HPV-16 E7。与这些观察结果一致,HPV-58 E7 下调细胞肿瘤抑制因子 pRb 的程度小于 HPV-16 E7。与表达 HPV-16 E7 的 PHK 相似,尽管存在高水平的 p53 和 p21,Cdk2 在表达 HPV-58 E7 的 PHK 中仍保持活性。有趣的是,HPV-58 E7 下调 p130 的效率高于 HPV-16 E7。我们的研究表明,HPV-58 E7 下调 pRb/p130 的能力与废除细胞周期检查点之间存在相关性,这也与 HPV-58 感染相关的宫颈癌进展的生物学风险相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9971/2818596/35c995947e24/nihms163372f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9971/2818596/ffbfbbe3ba8f/nihms163372f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9971/2818596/393405eedf48/nihms163372f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9971/2818596/2b4a7f67ed00/nihms163372f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9971/2818596/35c995947e24/nihms163372f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9971/2818596/ffbfbbe3ba8f/nihms163372f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9971/2818596/393405eedf48/nihms163372f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9971/2818596/2b4a7f67ed00/nihms163372f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9971/2818596/35c995947e24/nihms163372f4.jpg

相似文献

1
The human papillomavirus type 58 E7 oncoprotein modulates cell cycle regulatory proteins and abrogates cell cycle checkpoints.人乳头瘤病毒 58 型 E7 癌蛋白调节细胞周期调控蛋白并消除细胞周期检查点。
Virology. 2010 Feb 5;397(1):139-44. doi: 10.1016/j.virol.2009.10.051. Epub 2009 Nov 27.
2
Regulator of chromatin condensation 1 abrogates the G1 cell cycle checkpoint via Cdk1 in human papillomavirus E7-expressing epithelium and cervical cancer cells.染色质凝聚调控因子 1 通过 Cdk1 废除人乳头瘤病毒 E7 表达的上皮细胞和宫颈癌细胞中的 G1 细胞周期检验点。
Cell Death Dis. 2018 May 22;9(6):583. doi: 10.1038/s41419-018-0584-z.
3
Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.蛋白酶体降解 p130 促进高危型人乳头瘤病毒 16 和 18 E7 转染细胞的细胞周期失调和细胞分化障碍。
Mol Biol Rep. 2021 Jun;48(6):5121-5133. doi: 10.1007/s11033-021-06509-4. Epub 2021 Jun 24.
4
Role of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6.细胞周期蛋白依赖性激酶1(Cdk1)在人乳头瘤病毒E6对有丝分裂后检查点的p53非依赖性废除中的作用
J Virol. 2015 Mar;89(5):2553-62. doi: 10.1128/JVI.02269-14. Epub 2014 Dec 17.
5
Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells.人乳头瘤病毒 16 型 E6/E7 癌蛋白破坏抑制性 p130-DREAM 复合物是宫颈癌细胞周期进展所必需的。
J Gen Virol. 2011 Nov;92(Pt 11):2620-2627. doi: 10.1099/vir.0.035352-0. Epub 2011 Aug 3.
6
Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1.蛋白磷酸酶2A的癌性抑制剂通过E2F1促进人乳头瘤病毒癌蛋白E7诱导的细胞增殖。
Oncotarget. 2015 Mar 10;6(7):5253-62. doi: 10.18632/oncotarget.2867.
7
Low- and high-risk human papillomavirus E7 proteins regulate p130 differently.低危型和高危型人乳头瘤病毒 E7 蛋白对 p130 的调节作用不同。
Virology. 2010 May 10;400(2):233-9. doi: 10.1016/j.virol.2010.01.034. Epub 2010 Feb 26.
8
Genome-Wide Transcriptome Analysis of Human Papillomavirus 16-Infected Primary Keratinocytes Reveals Subtle Perturbations Mostly due to E7 Protein Expression.人类乳头瘤病毒 16 感染的原代角质形成细胞的全基因组转录组分析显示,大多数微小干扰是由于 E7 蛋白的表达。
J Virol. 2020 Jan 17;94(3). doi: 10.1128/JVI.01360-19.
9
Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.对表达人乳头瘤病毒16型E7癌蛋白的细胞中p53介导的G1期生长停滞途径的分析。
J Virol. 1997 Apr;71(4):2905-12. doi: 10.1128/JVI.71.4.2905-2912.1997.
10
Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.通过对表达E7的细胞进行转录谱分析确定WDHD1在人乳头瘤病毒介导的肿瘤发生中的作用
J Virol. 2016 Jun 10;90(13):6071-6084. doi: 10.1128/JVI.00513-16. Print 2016 Jul 1.

引用本文的文献

1
Human Papillomavirus 58 E7 T20I/G63S Variant Isolated from an East Asian Population Possesses High Oncogenicity.人乳头瘤病毒 58 E7 T20I/G63S 变异株源自东亚人群,具有高致癌性。
J Virol. 2020 Mar 31;94(8). doi: 10.1128/JVI.00090-20.
2
Oncogenic comparison of human papillomavirus type 58 E7 variants.人乳头瘤病毒 58 型 E7 变体的致癌性比较。
J Cell Mol Med. 2019 Feb;23(2):1517-1527. doi: 10.1111/jcmm.14059. Epub 2018 Dec 21.
3
Cdc6 contributes to abrogating the G1 checkpoint under hypoxic conditions in HPV E7 expressing cells.

本文引用的文献

1
Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.人乳头瘤病毒E7癌蛋白在宫颈癌发生过程中抑制p21Cip1的肿瘤抑制活性。
Cancer Res. 2009 Jul 15;69(14):5656-63. doi: 10.1158/0008-5472.CAN-08-3711. Epub 2009 Jul 7.
2
A dual role of Cdk2 in DNA damage response.Cdk2 在 DNA 损伤反应中的双重作用。
Cell Div. 2009 May 18;4:9. doi: 10.1186/1747-1028-4-9.
3
Binding of PDZ proteins to HPV E6 proteins does neither correlate with epidemiological risk classification nor with the immortalization of foreskin keratinocytes.
Cdc6 有助于在 HPV E7 表达细胞的低氧条件下消除 G1 检验点。
Sci Rep. 2017 Jun 7;7(1):2927. doi: 10.1038/s41598-017-03060-w.
4
Role of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6.细胞周期蛋白依赖性激酶1(Cdk1)在人乳头瘤病毒E6对有丝分裂后检查点的p53非依赖性废除中的作用
J Virol. 2015 Mar;89(5):2553-62. doi: 10.1128/JVI.02269-14. Epub 2014 Dec 17.
5
Role of Cdk1 in DNA damage-induced G1 checkpoint abrogation by the human papillomavirus E7 oncogene.细胞周期蛋白依赖性激酶1(Cdk1)在人乳头瘤病毒E7癌基因诱导的DNA损伤所致G1期检查点消除中的作用
Cell Cycle. 2014;13(20):3249-59. doi: 10.4161/15384101.2014.953879.
6
Gene chip technology used in the detection of HPV infection in esophageal cancer of Kazakh Chinese in Xinjiang Province.基因芯片技术用于检测新疆哈萨克族食管癌患者人乳头瘤病毒感染情况。
J Huazhong Univ Sci Technolog Med Sci. 2014 Jun;34(3):343-347. doi: 10.1007/s11596-014-1280-6. Epub 2014 Jun 18.
7
Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity.人乳头瘤病毒 58 型 E2 蛋白与 E7 蛋白的特定相互作用抑制 E7 介导的致癌性。
J Gen Virol. 2012 Jul;93(Pt 7):1563-1572. doi: 10.1099/vir.0.039354-0. Epub 2012 Mar 21.
8
Genomic Instability Induced By Human Papillomavirus Oncogenes.人乳头瘤病毒癌基因诱导的基因组不稳定性
N Am J Med Sci (Boston). 2010 Apr;3(2):43-47. doi: 10.7156/v3i2p043.
9
Calpain3 is expressed in a proteolitically active form in papillomavirus-associated urothelial tumors of the urinary bladder in cattle.钙蛋白酶 3 以蛋白水解活性形式在牛的与乳头瘤病毒相关的膀胱尿路上皮肿瘤中表达。
PLoS One. 2010 Apr 22;5(4):e10299. doi: 10.1371/journal.pone.0010299.
PDZ蛋白与HPV E6蛋白的结合既不与流行病学风险分类相关,也不与包皮角质形成细胞的永生化相关。
Virology. 2009 May 10;387(2):380-7. doi: 10.1016/j.virol.2009.02.018. Epub 2009 Mar 14.
4
Abrogation of the postmitotic checkpoint contributes to polyploidization in human papillomavirus E7-expressing cells.有丝分裂后检查点的废除导致人乳头瘤病毒E7表达细胞中的多倍体化。
J Virol. 2009 Mar;83(6):2756-64. doi: 10.1128/JVI.02149-08. Epub 2009 Jan 7.
5
The human papillomavirus E7 oncoprotein.人乳头瘤病毒E7癌蛋白
Virology. 2009 Feb 20;384(2):335-44. doi: 10.1016/j.virol.2008.10.006. Epub 2008 Nov 12.
6
Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.亚太地区特定类型人乳头瘤病毒感染及相关疾病的负担与趋势
Vaccine. 2008 Aug 19;26 Suppl 12:M1-16. doi: 10.1016/j.vaccine.2008.05.010.
7
Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes.人乳头瘤病毒16型(HPV16)E7癌蛋白与细胞周期蛋白A/细胞周期蛋白依赖性激酶2(cyclin A/CDK2)以及细胞周期蛋白E/细胞周期蛋白依赖性激酶2(cyclin E/CDK2)复合物的直接关联。
Virology. 2008 Oct 10;380(1):21-5. doi: 10.1016/j.virol.2008.07.017. Epub 2008 Aug 21.
8
Cellular mechanisms of tumour suppression by the retinoblastoma gene.视网膜母细胞瘤基因的肿瘤抑制细胞机制
Nat Rev Cancer. 2008 Sep;8(9):671-82. doi: 10.1038/nrc2399.
9
Human papillomavirus type 16 E7 oncoprotein associates with E2F6.人乳头瘤病毒16型E7癌蛋白与E2F6相关联。
J Virol. 2008 Sep;82(17):8695-705. doi: 10.1128/JVI.00579-08. Epub 2008 Jun 25.
10
Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.人乳头瘤病毒E7蛋白的酪蛋白激酶II基序依赖性磷酸化促进分化的人角质形成细胞中p130降解和S期诱导。
J Virol. 2008 May;82(10):4862-73. doi: 10.1128/JVI.01202-07. Epub 2008 Mar 5.